scholarly journals Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial

2018 ◽  
Vol 21 (1) ◽  
pp. 103-111 ◽  
Author(s):  
Ji Cheol Bae ◽  
Kyung Wan Min ◽  
Yong Hyun Kim ◽  
Kyoung-Ah Kim ◽  
Eun-Gyoung Hong ◽  
...  
2014 ◽  
Vol 20 (12) ◽  
pp. 1322-1332 ◽  
Author(s):  
Lawrence Blonde ◽  
Zinnia T. San Juan ◽  
Peggy Bolton

Sign in / Sign up

Export Citation Format

Share Document